The majority of patients with esophageal cancer are diagnosed at an advanced, incurable
stage. Palliation of symptoms, specifically dysphagia, is a crucial component to improve …

Background The combination of stent insertion and single high-dose brachytherapy is a
feasible and safe palliative treatment regimen in patients with unresectable oesophageal …

Background: Patients with advanced esophageal cancer often experience pain and
dysphagia, yet the optimal palliative management remains unclear. This retrospective study …

Malignant dysphagia is a common problem in patients with esophageal cancer. Endoscopic
stenting can resolve dysphagia caused by malignant stricture; however, controversy exists …

Purpose: The aim of this study was to assess the 6-months dysphagia-free survival,
improvement in swallowing function, complication rate, and overall survival in patients with …

Incidence of esophageal cancer (EC) is rising more rapidly in the Western world than that of
any other cancer. Despite advances in therapy, more than 50% of patients have incurable …

There are a wide variety of palliative treatments for esophageal cancer. The aim of most
treatments is to maintain oral food intake, which should stabilize or even improve quality of …

Background: Many patients with advanced malignant dysphagia are not suitable for
definitive treatment. The best option for palliation of dysphagia varies between patients. This …

Early spread of esophageal cancer and absence of symptoms in patients who have early
cancer results in the majority of patients presenting with incurable cancer. The primary …

Abstract Background. Patient-reported outcomes (PROs) and assessments of treatment-
related toxicity provide important information on the effect of palliative chemotherapy and/or …